Tokyo, Japan

Kenji Seri


Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1979-1982

Loading Chart...
3 patents (USPTO):Explore Patents

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

Title: Kenji Seri: A Tokyo-Based Inventor Making Strides in Pharmaceutical Innovations

Introduction: Kenji Seri, a distinguished inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals. With a strong background in chemistry and a passion for innovation, Seri has successfully obtained three patents in his career.

Latest Patents: Kenji Seri's latest patents include Benzaminoethylphenoxycyclohexylacetic acid derivatives and Substituted oxy-cyclohexylacetic acid derivatives. These compounds have shown promising potential as antihyperlipidemic agents, offering new possibilities in the treatment of lipid-related disorders.

Career Highlights: Kenji Seri is currently affiliated with Kaken Chemical Co., Ltd., a renowned pharmaceutical company in Japan. His expertise and dedication have played a crucial role in the development of novel pharmaceutical compounds aimed at improving human health and well-being.

Collaborations: Throughout his career, Kenji Seri has collaborated closely with esteemed colleagues such as Yasuhiko Hamazaki and Nobuo Ishiyama. Together, they have worked on groundbreaking research projects that have led to the successful patenting of innovative pharmaceutical compounds.

Conclusion: Kenji Seri's remarkable work as an inventor in the pharmaceutical industry showcases his commitment to pushing the boundaries of innovation. His patents reflect his creativity, expertise, and vision for developing cutting-edge solutions to address complex medical challenges. Seri's contributions continue to inspire and influence the field of pharmaceutical research, making him a respected figure in the global innovation landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…